Cargando…

Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine

In spite of the declining incidence of gastric cancer (GC) in recent years, the mortality rate is still high. The asymptomatic nature and nonspecific clinical manifestations combined with the lack of efficient screening programs delay the diagnosis of GC. Therefore, the prevalence of advanced gastri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wei, Beeharry, Maneesh K., Liu, Wentao, Yan, Min, Zhu, Zhenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220419/ https://www.ncbi.nlm.nih.gov/pubmed/28105420 http://dx.doi.org/10.1155/2016/3923585

Ejemplares similares

YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p/YWHAZ axis
por: Zhang, Tianqi, et al.
Publicado: (2021)

Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021)

Preoperative imaging evaluation of the absolute indication criteria for endoscopic submucosal dissection in early gastric cancer patients
por: Shi, Hong-peng, et al.
Publicado: (2020)

Long Noncoding RNA SNHG12 Promotes Gastric Cancer Proliferation by Binding to HuR and Stabilizing YWHAZ Expression Through the AKT/GSK-3β Pathway
por: Zhang, Tianqi, et al.
Publicado: (2021)

Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2020)

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2019)

Correction to: Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2019)

Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine
por: Wang, Zhijun, et al.
Publicado: (2016)

Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
por: Sah, Birendra Kumar, et al.
Publicado: (2021)

Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020)

Chemotherapy for gastric cancer patients – time for personalization in medicine?
por: Nowara, Elżbieta, et al.
Publicado: (2012)

Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
por: Beeharry, Maneesh Kumarsing, et al.
Publicado: (2020)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer
por: Wang, Wentao, et al.
Publicado: (2022)

Personal genomes and precision medicine
por: Highnam, Gareth, et al.
Publicado: (2012)

Personal genomes to precision medicine
por: Scaria, Vinod
Publicado: (2014)

Personalized and Precision Medicine 2022
por: Caminade, Anne-Marie
Publicado: (2023)

Precision medicine in gastric cancer
por: Bonelli, Patrizia, et al.
Publicado: (2019)

Precision Medicine Approaches to Diabetic Kidney Disease: Personalized Interventions on the Horizon
por: Nageeta, FNU, et al.
Publicado: (2023)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
por: Viswanathan, Thyla, et al.
Publicado: (2021)

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
por: Casolino, R., et al.
Publicado: (2021)

Personality, Preoperative Anxiety, and Postoperative Outcomes: A Review
por: Ji, Wentao, et al.
Publicado: (2022)

Personalized medicine in Parkinson's disease: Time to be precise
por: Titova, Nataliya, et al.
Publicado: (2017)

Personalized Proteomics: The Future of Precision Medicine
por: Duarte, Trevor T., et al.
Publicado: (2016)

Restoring the missing person to personalized medicine and precision psychiatry
por: Gómez-Carrillo, Ana, et al.
Publicado: (2023)

Precision Medicine for Personalized Cancer Therapy
por: Wong, Ada Hang-Heng, et al.
Publicado: (2015)

Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021)

From Personalized Medicine to Precision Psychiatry?
por: Češková, Eva, et al.
Publicado: (2021)

Translational, Precision, and Personalized Medicine in Gastroenterology
por: Candelli, Marcello
Publicado: (2022)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Preoperative Splenic Density for the Prediction of Survival and Adjuvant Chemotherapy Benefits in Gastric Cancer
por: Zhang, Wei-teng, et al.
Publicado: (2020)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022)

DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer
por: Fan, Zhiyuan, et al.
Publicado: (2022)

Artificial intelligence, radiology, precision medicine, and personalized medicine
por: Leite, Claudia da Costa
Publicado: (2019)

Prognostic factors influencing the survival of patients with carcinoma of the gastric cardia receiving preoperative interventional embolization chemotherapy
por: Cao, Hai-Li, et al.
Publicado: (2017)

Precision Medicine, AI, and the Future of Personalized Health Care
por: Johnson, Kevin B., et al.
Publicado: (2020)

Precision Medicine in Interventional Cardiology
por: Hokken, Thijmen W, et al.
Publicado: (2020)

Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer
por: Drake, Justin A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pf7vuh7doqiavc0adcndg6ut0e